Synthetic DNA manufacturing: From first experiment to first-in-human

4basebio makes synthetic DNA at every manufacturing level, from research-grade material for your first test to GMP DNA for late-stage trials. One cell-free process, three phase-appropriate grades, made in Cambridge, UK under our MHRA GMP license.

Phase appropriate manufacturing to meet your drug development requirements

OUR GRADES

Choose the phase appropriate manufacturing that fits where your programme is today. Every service level uses the same cell-free manufacturing process, so your DNA never means changing as you programme progresses through the clinic.

DNA FOR FOR NON-CLINICAL USE

Research Use Only

Test it in your own system.

For discovery, in vitro studies, process screening and head-to-head comparison against plasmid.

Explore RUO →

DNA FOR CLINICAL USE

GMP ClinicalStart

Fast to first-in-human.

For Phase 1/2A trials, plus the toxicology, engineering and stability runs that lead into them.

Explore GMP ClinicalStart →

DNA FOR CLINICAL USE

GMP

Fully validated equipment, process and analytical methods.

For Phase 2B onward and commercial supply, delivered to you or directly to your CDMO.

Explore GMP →

RESEARCH USE ONLY

Test it in your own system

See how synthetic DNA performs before you commit a programme to it. RUO material is made in our R&D environment on calibrated equipment and ships with a Certificate of Analysis.

Ideal for: discovery, in vitro studies, process screening, and comparison against your current plasmid DNA.

What you get:

•         Off-the-shelf constructs for mRNA and AAV production, or your custom sequence from 1 mg  to 50 mg

•         Certificate of Analysis with every batch

•         Research-grade materials, fit-for-purpose testing

GMP CLINICAL START

Fast to first-in-human

GMP ClinicalStart is DNA built for Phase 1/2A trials, where data quality and traceability matter. It is made in accordance with our MHRA GMP licence in dedicated EU GMP Grade D suites, with qualified equipment and defined in-process and release criteria. A streamlined approach keeps early-phase programmes moving.

What you get:

•         Qualified product contact equipment and a qualified process

•         CoA-inspected materials

•         Qualified testing with a wider range of release specifications

•         Full QA oversight and release, with a TSE/BSE-free certificate

•         A standard quality agreement, with oversight of deviations, OOS results and change control

GMP

Fully validated process and analytical methods

GMP DNA is phase-appropriate material for late-stage clinical manufacture, made under our MHRA GMP licence in dedicated EU GMP Grade D suites. A well-defined process runs under our GMP quality management system with full batch records. It is the same cell-free process as GMP ClinicalStart, so there is no process change as your programme grows.

Ideal for: Phase 2B onward and commercial supply, for mRNA and viral vector manufacture in-house or through your CDMO.

What you get:

•         Qualified product contact equipment and a qualified process

•         CoA-inspected materials

•         Qualified testing with a wider range of release specifications

•         Full QA oversight and release, with a TSE/BSE-free certificate

•         A standard quality agreement, with oversight of deviations, OOS results and change control

COMPARE GRADES

Phase-appropriate manufacturing

For DNA used to make mRNA or viral vectors.

SPECIFICATION RUO GMP ClinicalStart GMP
Manufacturing scale 1 mg – 1 g Minimum: 25 mg
PCV: 5 mg+
Minimum: 50 mg
PCV: 5 mg+
Environment R&D EU GMP Grade D, dedicated EU GMP Grade D, dedicated
Product contact equipment Calibrated Qualified Validated
Materials Research grade CoA inspected Qualified
Certificate of Analysis ✓ ✓ ✓
Testing and specifications — Qualified, wider range Validated, specific
TSE/BSE-free certificate — ✓ ✓
Full QA oversight and release — ✓ ✓
Quality agreement — Standard Standard
Deviation, OOS and change control oversight — ✓ ✓

Get the controls your stage needs, without paying for what it doesn't. Use the toggle to switch between DNA as starting material and DNA as drug substance.

WHICH GRADE IS RIGHT FOR YOU?

Find your grade in two questions

Not sure, or your QA team has specific requirements for suppliers? We'll help you choose the right grade for your filing.

QUESTION 1 OF 2
Will this material be used in a clinical trial in humans?
QUESTION 2 OF 2
Which trial phase are you supplying?

One process from bench to late phase

WHY 4BASEBIO

Same DNA, same process.

Our cell-free process stays the same from RUO through GMP. As your programme advances, the controls step up, but the process doesn't change, so you avoid comparability work between phases.

Phase-appropriate, not one-size.

Early programmes get the speed they need. Late-phase programmes get validated methods and analytics packages built around their stage and filing. You pay for what your programme needs.

Licensed and documented.

We manufacture under our MHRA GMP licence in dedicated EU GMP Grade D suites, with full batch records under our GMP quality management system.

Works with your CDMO.

We supply DNA directly to you or to your mRNA or viral vector manufacturer, including material for their engineering runs so they're ready when your GMP batch arrives.

A second source with a different route.

Synthetic DNA can sit alongside your current plasmid supplier, giving you a different manufacturing route as a supply hedge.

Frequently asked questions

Ready to move your DNA forward?

Tell us where your programme is today and we'll recommend the right grade, with a quote to match.